Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 240 of 5804
-
New hope for tough pancreatic cancer? drug combo targets KRAS mutations
Disease control Not yet recruitingThe purpose of this study is to determine the safety and efficacy of pan KRAS inhibitor JAB-23E73 in combination with nab-paclitaxel and gemcitabine in participants with metastatic PDAC harboring KRAS gene alterations.
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Herbal dripping pills aim to boost exercise capacity in heart failure
Disease control Recruiting nowThis trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted from Coronary Heart Disease (Syndrome of Qi Deficiency with Blood Stasis).
Phase: PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Old drugs, new hope: could a thalidomide combo free thalassemia patients from transfusions?
Disease control Not yet recruitingThe aim of this study is to determine the safety and therapeutic effect of HbF inducers (combination therapy: thalidomide and hydroxyurea) on beta thalassemia patients. The main objectives of this study are: * To determine the therapeutic efficacy of HbF inducers (combination th…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for tough bladder cancer: experimental drug SYS6002 faces chemo in major trial
Disease control Not yet recruitingThis study is a randomized, controlled, open-label, multicenter phase III clinical trial, which aims to evaluate the efficacy,safety PK characteristics, and immunogenicity of SYS6002 compared with chemotherapy in participants with locally advanced or metastatic urothelial carcino…
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for bladder cancer: targeted drug combo aims to boost survival
Disease control Not yet recruitingThis is a multicenter, randomized controlled clinical trial (HOPE-07) designed to evaluate the efficacy and safety of perioperative treatment with disitamab vedotin (RC48) combined with toripalimab compared with toripalimab combined with chemotherapy in patients with resectable H…
Phase: PHASE2, PHASE3 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Diabetes drug may double as brain protector in new trial
Disease control OngoingThis study is a prospective, randomized, open-label trial with blinded outcome assessment (PROBE design) designed to evaluate the effects of sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy on cognitive function in adults with type 2 diabetes mellitus (T2D). A total of 20…
Phase: NA • Sponsor: University of Primorska • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug QLC5508 takes on chemo in prostate cancer battle
Disease control Not yet recruitingThis is a randomized, open-label, active-controlled, multicenter Phase III trial evaluating QLC5508 versus docetaxel in participants with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after prior treatment with novel hormonal agents (NHAs). Participa…
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Massive RSV vaccine study uses real-world data to see if shots prevent severe illness
Disease control Not yet recruitingAmong non-pregnant adults observed in Epic Cosmos since August 2023 who are eligible for RSV vaccination, what is the effectiveness of ABRYSVO® (RSVpreF), compared with unvaccinated individuals, in preventing RSV-related and all-cause acute respiratory illness (ARI), lower respir…
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for rare leukemia: Four-Drug cocktail targets cancer cells
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether CM336, a BCMA/CD3 bispecific antibody, can improve treatment outcomes when combined with isatuximab, lenalidomide, and bortezomib in adults with newly diagnosed primary plasma cell leukemia (pPCL). The study will also evaluate t…
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Targeted radiation delivered directly to brain tumor cavity in new trial
Disease control Recruiting nowThe primary objective of this study is to evaluate the dosimetry, safety, and tolerability of the investigational radiopharmaceutical \[177Lu\]Lu-XT771 in patients with recurrent glioblastoma, an aggressive form of brain cancer. \[177Lu\]Lu-XT771 is designed to specifically targe…
Phase: EARLY_PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a thyroid boost help tiny preemies grow smarter and stronger?
Disease control Not yet recruitingThe primary objective of this clinical trail is to evaluate whether early supplementation of levothyroxine (L-T4) at a dosage of 8 ug/kg/d, initiated in the second week of life, improves physical growth and neurodevelopmental outcomes at 2 years of corrected age in Small for Gest…
Phase: NA • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Cream-and-Steroid combo aims to recolor vitiligo patches
Disease control Not yet recruitingThis study is a prospective, multicenter, real-world observational study to assess the clinical efficacy and safety of topical 1.5% Ruxolitinib phosphate cream used in combination with systemic corticosteroids in a real-world clinical setting. The study plans to observe patients …
Sponsor: ShanShan Li • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a new drug boost Semaglutide's power against diabetes and obesity?
Disease control Recruiting nowThe goal of this clinical trial is to learn if AT673 contributes to additional weight loss and glycemic control when given with semaglutide in participants with overweight/obesity and type 2 diabetes. The main questions it aims to answer are: * To compare the effect on body weig…
Phase: PHASE2 • Sponsor: Antag Therapeutics • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Blood test could guide anal cancer treatment, reducing side effects
Disease control Recruiting nowThis study is for people who have anal cancer and have not yet had treatment. The regular treatment for people who have anal cancer is chemoradiation therapy (CRT). CRT is when chemotherapy and radiation therapy are given at the same time. Studies show that CRT works well to trea…
Phase: PHASE2 • Sponsor: Jennifer Dorth • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill could regrow hair in severe alopecia – trial begins
Disease control Recruiting nowThis study evaluates the efficacy and safety of deuruxolitinib in Japanese Adults between 18 and 65 years of age who have 50% or greater scalp hair loss.
Phase: PHASE3 • Sponsor: Sun Pharma Japan Limited • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
AI ultrasound could bring lifesaving pregnancy checks to remote villages
Diagnosis Recruiting nowFS2 evaluates the diagnostic accuracy and implementation feasibility of an AI-assisted blind-sweep obstetric ultrasound (SPAQ E-con AI), operated by trained non-specialist health workers, for antenatal screening in rural Democratic Republic of the Congo. Primary outcomes are gest…
Sponsor: SOIK Corporation Sarl • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New hope for tough ovarian cancer: phase 3 trial of Mo-Rez drug launches
Disease control Recruiting nowThis study specifically aims to evaluate how well mocertatug rezetecan (Mo-Rez) works in treating ovarian cancer compared to standard treatments. The study also assesses whether Mo-Rez is safe and tolerated well by participants compared to standard treatments and aims to provide …
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Brain zaps after trauma may stop PTSD before it starts
Prevention Recruiting nowPTSD is one of the most universal and severe psychiatric disorders whose incidence continues to rise due to the common exposure to severe trauma in the United States and worldwide. After trauma, a proportion of individuals maintains high symptoms of PTSD and depression, which can…
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New inhaled treatment aims to save lungs and reduce ventilator time in ICU patients
Disease control Recruiting nowThis is a multicentre, double-blind, placebo-controlled Phase III randomized clinical trial designed to evaluate the efficacy and safety of inhaled aprotinin in adult patients with moderate or severe acute respiratory distress syndrome (ARDS). A total of 156 critically ill patien…
Phase: PHASE3 • Sponsor: Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy targets tough lung cancer
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of AK138D1 as monotherapy or in combination with ivonescimab in patients with advanced non-small cell lung cancer. Participants will receive study treatment with AK138D1 alone or in combination…
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC